Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03152279 · ClinicalTrials.gov registry record
Assessment of Duodenal Epithelial Integrity in Celiac Disease With Mucosal Impedance
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 33
- Enrollment target
NCT03152279 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 33 participants.
The verdict
NCT03152279 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
Increased intestinal permeability can represent compromise of the epithelium's integrity and is thought to be the primary mechanism in patients who develop Celiac Disease (CeD) and non-celiac gluten sensitivity when gluten peptides cross the barrier and trigger an immune response. In this study, the investigators propose to use a novel, minimally invasive technology to detect mucosal damage (i.e. barrier dysfunction) in the duodenal epithelium. The primary aim of this study is to identify if there is a difference in duodenal mucosal impedance between CeD and control patients.
Interventions
- DIAGNOSTIC_TEST Blood sample
- DIAGNOSTIC_TEST Mucosal Impedance Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-11-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03152279
The ClinicalTrials.gov registry entry for NCT03152279 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood sample is the first listed.
NCT03152279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03152279 about?
NCT03152279 is a clinical study titled "Assessment of Duodenal Epithelial Integrity in Celiac Disease With Mucosal Impedance". Increased intestinal permeability can represent compromise of the epithelium's integrity and is thought to be the primary mechanism in patients who develop Celiac Disease (CeD) and non-celiac gluten sensitivity when gluten peptides cross the barrier and trigger an immune response. In this study, the...
What is the current status of trial NCT03152279?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2016-12. Estimated completion is 2018-11-14.
What interventions are being tested in trial NCT03152279?
The interventions under investigation include: Blood sample (DIAGNOSTIC_TEST), Mucosal Impedance Catheter (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03152279?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.